Advanced Wound Care Market Development & Application: Biological and Anti-Microbial Dressings to 22,088.6 million USD by 2024

Global advanced wound care is expected to reach USD 22,088.6 million by 2024 from USD 11,683.5 million in 2016, at a CAGR of 8.4% in the forecast period 2017 to 2024. The new market report contains data for historic years 2015, the base year of calculation is 2016 and the forecast period is 2017 to 2024.

Avail 10% discount on direct purchase kindly send the email @ sopan.gedam@databridgemarketresearch.com

Major Players:

Some of the prominent players in the advanced wound care market are 3M, Smith and Nephew, Medtronic, Acelity L.P. INC, Molnlycke Healthcare AB, Convatec Inc, Baxter, Coloplast, Ethicon. Inc, Hollister Inc, Integra Life Sciences Corporation, Derma Sciences Inc, Spiracur Inc, Medline Industries, Mimedx Group, Organogenesis Inc, Talley Group, BSN Medical, Devon Medical Products, Human Biosciences Inc, B.Braun Melsungen AG, Cardinal Health, Paul Hartmann Limited, DeRoyal Industries Inc, DermaRite Industries LLC, MPM Medical Inc, Kinetic Concepts, Advancis Medical and many others.

This report consists of below pages:

• No of pages: 403
• No of Figures: 24
• No of Tables: 434

Get Free Sample Report @ http://databridgemarketresearch.com/request-a-sample/?dbmr=global-advanced-wound-care-market

Market Segmentation:

The global advanced wound care market is segmented into three product types, namely, dressing, biologics, and therapy devices. In 2017, dressing segment is expected to dominate the global advanced wound care market with around 51.0% market share and is expected to dominate in the forecast period 2017 to 2024. However, biologics segment is expected to grow at the highest CAGR in the forecast period.

Based on dressing type, the market is segmented into foam dressing, hydrogels, film dressings, alginates, wound contact layer and super absorbent dressing. In 2017, film dressing segment is expected to dominate the global advanced wound care market.

Based on biologics type, the market is segmented synthetic into skin grafts, growth factors, allografts and xenografts.

Based on wound care growth factor type, the market is segmented into platelet derived growth factor (PDGF), platelet rich plasma (PRP), epidermal growth factor (EGF), basic fibroblast growth factor (BFGF), granulocyte colony stimulating factor (G-CSF), talactoferrin ALFA, thrombin peptide (TP508) and keratinocyte growth factor (KGF).

Based on wound care therapy devices type, the market is segmented into negative pressure wound therapy (NPWT), pressure relief devices (PRD), wound debridement devices, hyberbaric oxygen chambers and physical therapies.

Based on NPWT type, the market is segmented into stand alone NPWT devices, portable NPWT devices and disposable NPWT devices.

Based on PRD type, the market is segmented into mattress and bed.

Based on hyberbaric oxygen chambers type, the market is segmented into monoplace, multiplace and topical.

Based on wound debridement devices type, the market is segmented into hydrosurgical, ultrasound, and mechanical among others.

Based on physical therapies type, the market is segmented into laser therapy, electrical simulation, external shock wave therapies and saline mist therapy.

Based on wound type, the market is segmented into surgical wound, diabetic ulcer, burns, pressure ulcer, venous ulcer among others. Diabetic ulcers segment is expected to grow at the highest CAGR of in the forecast period.

On the basis of end users, the market is classified into hospitals, wound care centers, ambulatory centers, home healthcare, clinics, and community healthcare. In 2017, hospitals segment is expected to dominate the global advanced wound care market and is expected to dominate in the forecast period 2017 to 2024.

On the basis of distribution channel the market is segmented into direct tenders, and retails.

To Buy Complete Report Click Here @ http://databridgemarketresearch.com/inquire-before-buying/?dbmr=global-advanced-wound-care-market

Drivers:

Some of the major factors driving the growth of market for advanced wound care market, such as technological advancement, rising incidences of chronic wound, government support, rising geriatric population and increasing trend.

RISING GERIATRIC POPULATION

With our aging population, diseases that compromise skin integrity such as diabetes, skin breakdown with ulcer and chronic wound formation is a frequent consequence. Type of wounds includes pressure ulcers, surgical wounds, venous ulcers, traumatic wounds, arterial wounds, diabetic ulcers and chronic ulcers. There is a strong correlation between age and the incidence of diseases requiring wound products.

TECHNOLOGICAL ADVANCEMENT

Wounds are unique in as far as no disease other than wounds would have existed from the beginning of mankind. Over the years, the management of wounds, especially that of chronic wounds, have enormous social and economic implications worldwide. The increasing prevalence of chronic wounds is driving demand for products which better enhance quality of life and limit the risk of more serious health problems. As a result treatment and management is moving from traditional wound care products to more advanced offerings which provide an optimal healing environment. These advanced technologies include foam, alginates, gelling fibrous dressings and anti infective substances such as silver. Continuous advances made in the study of the wound, an ever-broadening understanding of the path physiology of wounds, and advanced technology in monitoring the response of healing has led to continuous developments in the treatment of different wounds.

RISING INCIDENCES OF CHRONIC WOUND

Chronic wounds are rarely seen in individuals. In fact, chronic wound patients frequently suffer from “highly branded” diseases such as diabetes and obesity. Some of the most common types of wounds are Infectious wounds, Ischemic wounds, radiation poisoning wounds and surgical wounds. Ulcers is the most common type of chronic wounds, some of the most common types of ulcers are arterial ulcers, venous ulcers, diabetic ulcers and pressure ulcer. Tree of Chronic wound is growing steadily; it increases incidence of chronic wound in individuals. People are suffering from different type of wounds and ulcers.

GOVERNMENT SUPPORT

Wound healing is an inherent ability of an organism to protect itself against injuries. Government of every region support in the form of funding for advance wound care development, innovations and helps in increasing trend towards preventive healthcare. For instance, Willingsford a small British company is to receive government grant to develop its innovative wound treatment.

View Full Report @ http://databridgemarketresearch.com/reports/global-advanced-wound-care-market/

Key Topics Mentioned:

1. INTRODUCTION

1.1. OVERVIEW OF GLOBAL ADVANCED WOUND CARE MARKET
1.2. CURRENCY AND PRICING
1.3. LIMITATION
1.4. MARKETS COVERED

2. MARKET SEGMENTATION

2.1. MARKETS COVERED
2.2. GEOGRAPHIC SCOPE
2.3. YEARS CONSIDERED FOR THE STUDY
2.4. CURRENCY AND PRICING
2.5. RESEARCH METHODOLOGY
2.6. PRIMARY INTERVIEWS WITH KEY OPINION LEADERS
2.7. SECONDARY SOURCES
2.8. ASSUMPTIONS

3. MARKET OVERVIEW

3.1. DRIVERS

3.1.1. RISING AGING AND GERIATRIC POPULATION
3.1.2. TECHNOLOGICAL ADVANCEMENT
3.1.3. GOVERNMENT SUPPORT
3.1.4. RISING INCIDENCES OF CHRONIC WOUND
3.1.5. INCREASING TREND

3.2. RESTRAINTS

3.2.1. LOW AWARENESS
3.2.2. SLOW GROWTH RATE AND SHRINKING MARKET
3.2.3. COMPLEX REGULATORY APPROVAL PROCESS
3.2.4. COMPETITION WITH OTHER MOIST DRESSINGS

3.3. OPPORTUNITIES

3.3.1. REIMBURSEMENT
3.3.2. MERGERS AND ACQUISITIONS TO EXPAND BUSINESS
3.3.3. UNMET NEED
3.3.4. INCREASING DEMAN

3.4. CHALLENGE

3.4.1. SHORTAGE OF TRAINED STAFF
3.4.2. THE DEVELOPMENT OF SUBSTITUTE PRODUCTS

3.5. KEY MARKET TRENDS AND UPCOMMING TECHNOLOGIES

3.5.1. SMART DRESSING WILL PUSH FUTURE GROWTH
3.5.2. HYDROFIBER HAS BEEN THE MOST SIGNIFICANT RECENT INNOVATION
3.5.3. ALGINATE DRESSING IS EXPECTED TO GROW ROBUSTLY IN THE UPCOMING YEARS
3.5.4. FOAM DRESSING ACCOUNTING THE LARGEST MARKET SEGMENT IN THE UPCOMING YEARS

4. EXECUTIVE SUMMARY

5. PREMIUM INSIGHTS

6. GLOBAL ADVANCED WOUND CARE MARKET, BY PRODUCT TYPE

6.1. OVERVIEW
6.2. DRESSING
6.3. BIOLOGICS
6.4. THERAPY DEVICES

7. GLOBAL ADVANCED WOUND CARE MARKET, BY WOUND TYPE

7.1. INTRODUCTION

7.2. SURGICAL WOUND

7.2.1. CLASS I
7.2.2. CLASS II
7.2.3. CLASS III
7.2.4. CLASS IV

7.3. DIABETIC ULCERS

7.4. PRESSURE ULCERS

7.5. VENOUS ULCERS

7.6. BURNS

8. GLOBAL ADVANCED WOUND CARE MARKET, BY END USER

8.1. OVERVIEW

9. GLOBAL ADVANCED WOUND CARE MARKET, BY DISTRIBUTION CHANNEL

9.1. OVERVIEW

10. GLOBAL ADVANCED WOUND CARE MARKET, BY GEOGRAPHY

10.1. OVERVIEW

10.2. NORTH AMERICA ADVANCED WOUND CARE MARKET

10.2.1. U.S. ADVANCED WOUND CARE MARKET
10.2.2. CANADA ADVANCED WOUND CARE MARKET
10.2.3. MEXICO ADVANCED WOUND CARE MARKET

10.3. APAC ADVANCED WOUND CARE MARKET

10.3.1. JAPAN ADVANCED WOUND CARE MARKET
10.3.2. CHINA ADVANCED WOUND CARE MARKET
10.3.3. SOUTH KOREA ADVANVCED WOUND CARE MARKET
10.3.4. INDIA ADVANCED WOUND CARE MARKET
10.3.5. AUSTRALIA ADVANCED WOUND CARE MARKET
10.3.6. THAILAND ADVANCED WOUND CARE MARKET
10.3.7. SINGAPORE ADVANCED WOUND CARE MARKET
10.3.8. MALAYSIA ADVANVCED WOUND CARE MARKET
10.3.9. PHILIPPINESADVANCED WOUND CARE MARKET
10.3.10. INDONESIA ADVANCED WOUND CARE MARKET
10.3.11. REST OF APAC ADVANCE WOUND CARE MARKET

10.4. SOUTH AMERICA ADVANCED WOUND CARE MARKET

10.4.1. BRAZIL ADVANCED WOUND CARE MARKET
10.4.2. REST OF SOUTH AMERICA ADVANCED WOUND CARE MARKET

10.5. EUROPE ADVANCED WOUND CARE MARKET

10.5.1. GERMANY ADVANCED WOUND CARE MARKET
10.5.2. FRANCE ADVANCED WOUND CARE MARKET
10.5.3. U.K. ADVANCED WOUND CARE MARKET
10.5.4. ITALY ADVANCED WOUND CARE MARKET
10.5.5. SPAIN ADVANCED WOUND CARE MARKET
10.5.6. SWITZERLAND ADVANCED WOUND CARE MARKET
10.5.7. NETHERLANDS ADVANCED WOUND CARE MARKET
10.5.8. RUSSIA ADVANCED WOUND CARE MARKET
10.5.9. BELGIUM ADVANCED WOUND CARE MARKET
10.5.10. TURKEY ADVANCED WOUND CARE MARKET
10.5.11. REST OF EUROPE ADVANCED WOUND CARE MARKET

10.6. MEA ADVANCED WOUND CARE MARKET

10.6.1. SOUTH AFRICA ADVANCED WOUND CARE MARKET
10.6.2. SAUDI ARABIA ADVANCED WOUND CARE MARKET
10.6.3. UAE ADVANCED WOUND CARE MARKET
10.6.4. REST OF MEA ADVANCED WOUND CARE MARKET

11. GLOBAL ADVANCED WOUND CARE MARKET, COMPANY SHARE

11.1. COMPANY SHARE ANALYSIS: GLOBAL
11.2. COMPANY SHARE ANALYSIS: NORTH AMERICA
11.3. COMPANY SHARE ANALYSIS: EUROPE
11.4. COMPANY SHARE ANALYSIS: ASIA-PACIFIC (APAC)
11.5. COMPANY SHARE ANALYSIS: MIDDLE EAST AND AFRICA (MEA)
11.6. COMPANY SHARE ANALYSIS: SOUTH AMERICA

12. COMPANY PROFILES

12.1. ACELITY L.P. INC.

12.1.1. COMPANY OVERVIEW
12.1.2. REVENUE ANALYSIS
12.1.3. PRODUCT PORTFOLIO
12.1.4. RECENT DEVELOPMENTS

12.2. SMITH AND NEPHEW

12.2.1. COMPANY OVERVIEW
12.2.2. REVENUE ANALYSIS
12.2.3. PRODUCT PORTFOLIO
12.2.4. RECENT DEVELOPMENTS

12.3. MOLNLYCKE HEALTHCARE

12.3.1. COMPANY OVERVIEW
12.3.2. REVENUE ANALYSIS
12.3.3. PRODUCT PORTFOLI
12.3.4. RECENT DEVELOPMENTS

12.4. CONVATEC INC.

12.4.1. COMPANY OVERVIEW
12.4.2. REVENUE ANALYSIS
12.4.3. PRODUCT PORTF
12.4.4. RECENT DEVELOPMENTS

12.5. 3M

12.5.1. COMPANY OVERVIEW
12.5.2. REVENUE ANALYSIS
12.5.3. PRODUCT PORTFOLIO
12.5.4. RECENT DEVELOPMENTS

12.6. BAXTER

12.6.1. COMPANY OVERVIEW
12.6.2. REVENUE ANALYSIS
12.6.3. PRODUCT PORTFOLIO
12.6.4. RECENT DEVELOPMENTS

12.7. COLOPLAST

12.7.1. COMPANY OVERVIEW
12.7.2. REVENUE ANALYSIS
12.7.3. PRODUCT PORTFOLIO
12.7.4. RECENT DEVELOPMENTS

12.8. ETHICON INC

12.8.1. COMPANY OVERVIEW
12.8.2. REVENUE ANALYSIS
12.8.3. PRODUCT PORTFOLIO
12.8.4. RECENT DEVELOPMENTS

12.9. INTEGRA LIFE SCIENCES CORPORATION

12.9.1. COMPANY OVERVIEW
12.9.2. REVENUE ANALYSIS
12.9.3. PRODUCT PORTFOLIO
12.9.4. RECENT DEVELOPMENTS

12.10. DERMA SCIENCES INC

12.10.1. COMPANY OVERVIEW
12.10.2. REVENUE ANALYSIS
12.10.3. PRODUCT PORTFOLIO
12.10.4. RECENT DEVELOPMENTS

12.11. PAUL HARTMANN LIMITED

12.11.1. COMPANY OVERVIEW
12.11.2. REVENUE ANALYSIS
12.11.3. PRODUCT PORTFOLIO

12.12. ORGANOGENESIS INC

12.12.1. COMPANY OVERVIEW
12.12.2. REVENUE ANALYSIS
12.12.3. PRODUCT PORTFOLIO
12.12.4. RECENT DEVELOPMENTS

Related Report

Global Tumour Ablation Market – Trends and Forecast to 2024

Global Tumour Ablation Market, By Type (Tumour Ablation Systems (Radio Frequency Ablation, Microwave Ablation, HIFU, Laser Ablation, Cryoablation), Image Guidance Products, Accessories), By Cancer Type (Liver, Lings, Kidney, Brain, Bone, Pancreas, Breast, Others), By End-User (Hospitals, Oncology Clinics, Others), By Geography (North America, South America, Europe, Asia-Pacific, Rest of the World) – Trends and Forecast to 2024

Report Access: http://databridgemarketresearch.com/reports/global-tumour-ablation-market/

About Data Bridge Market Research:
Data Bridge Market Research set forth itself as an unconventional and neoteric Market research and consulting firm with unparalleled level of resilience and integrated approaches. We are determined to unearth the best market opportunities and foster efficient information for your business to thrive in the market. Data Bridge endeavors to provide appropriate solutions to the complex business challenges and initiates an effortless decision-making process.

Contact:
Vishal Dixit
Data Bridge Market Research
Tel: +1-888-387-2818
Email: sopan.gedam@databridgemarketresearch.com

This release was published on openPR.